Axcelis Technologies, Inc. (ACLS)
NASDAQ: ACLS · Real-Time Price · USD
44.79
+0.17 (0.38%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Company Description
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.
The company offers high energy, high current, and medium current implanters for various application requirements.
It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.
The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force.
Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.
Axcelis Technologies, Inc.
Country | United States |
Founded | 1995 |
IPO Date | Jul 11, 2000 |
Industry | Semiconductor Equipment & Materials |
Sector | Technology |
Employees | 1,524 |
CEO | Russell Low |
Contact Details
Address: 108 Cherry Hill Drive Beverly, Massachusetts 01915-1088 United States | |
Phone | 978 787 4000 |
Website | axcelis.com |
Stock Details
Ticker Symbol | ACLS |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001113232 |
CUSIP Number | 054540208 |
ISIN Number | US0545402085 |
Employer ID | 34-1818596 |
SIC Code | 3559 |
Key Executives
Name | Position |
---|---|
Dr. Russell J. Low Ph.D. | Chief Executive Officer, President and Director |
James G. Coogan | Executive Vice President and Chief Financial Officer |
Gregory F. Redinbo Ph.D. | Executive Vice President of Marketing and Applications |
Gerald M. Blumenstock | Executive Vice President of Research, Development and Engineering |
Dr. Christopher J. Tatnall Ph.D. | Executive Vice President of Global Customer Operations |
Robert Mahoney | Senior Vice President of Global Operations |
David Ryzhik | Senior Vice President of Investor Relations and Corporate Strategy |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 31, 2025 | ARS | Filing |
Mar 31, 2025 | DEF 14A | Other definitive proxy statements |
Mar 12, 2025 | 8-K | Current Report |
Feb 28, 2025 | 10-K | Annual Report |
Feb 10, 2025 | 8-K | Current Report |
Jan 30, 2025 | SCHEDULE 13G/A | Filing |
Jan 10, 2025 | 8-K | Current Report |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 7, 2024 | 10-Q | Quarterly Report |
Nov 6, 2024 | 8-K | Current Report |